Astera Labs, Inc. $ALAB Holdings Increased by Atreides Management LP

Key Points

• Atreides Management LP increased its stake in Astera Labs, Inc. by 153.3% during the first quarter, now owning 4,652,264 shares valued at approximately $277.6 million.
• Insider trading reports revealed that CEO Jitendra Mohan and CFO Michael Truett Tate sold significant amounts of stock, decreasing their ownership by 25.31% and 16.16%, respectively.
• Astera Labs reported $191.93 million in revenue for the last quarter, a 149.5% increase from the same quarter last year, and beat earnings estimates by $0.11 per share.

Atreides Management LP raised its stake in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 153.3% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,652,264 shares of the company's stock after buying an additional 2,815,614 shares during the quarter. Astera Labs comprises 8.4% of Atreides Management LP's portfolio, making the stock its 3rd largest holding. Atreides Management LP owned approximately 2.82% of Astera Labs worth $277,601,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also added to or reduced their stakes in the stock. Vanguard Group Inc. grew its holdings in Astera Labs by 0.9% during the 1st quarter. Vanguard Group Inc. now owns 9,297,476 shares of the company's stock valued at $554,780,000 after buying an additional 85,846 shares in the last quarter. Driehaus Capital Management LLC increased its position in shares of Astera Labs by 16,640.4% in the fourth quarter. Driehaus Capital Management LLC now owns 1,324,330 shares of the company's stock worth $175,408,000 after purchasing an additional 1,316,419 shares during the last quarter. Bank of Nova Scotia raised its stake in Astera Labs by 3,742.2% in the first quarter. Bank of Nova Scotia now owns 964,400 shares of the company's stock valued at $57,546,000 after purchasing an additional 939,300 shares in the last quarter. Polar Capital Holdings Plc bought a new stake in Astera Labs during the fourth quarter valued at approximately $126,812,000. Finally, BNP Paribas Financial Markets grew its stake in Astera Labs by 4,172.8% in the 4th quarter. BNP Paribas Financial Markets now owns 816,619 shares of the company's stock worth $108,161,000 after buying an additional 797,507 shares in the last quarter. Hedge funds and other institutional investors own 60.47% of the company's stock.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, COO Sanjay Gajendra sold 91,441 shares of the company's stock in a transaction that occurred on Monday, August 18th. The stock was sold at an average price of $183.51, for a total transaction of $16,780,337.91. Following the transaction, the chief operating officer owned 2,170,877 shares in the company, valued at approximately $398,377,638.27. This represents a 4.04% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Jack R. Lazar sold 22,500 shares of the stock in a transaction that occurred on Wednesday, August 27th. The stock was sold at an average price of $178.42, for a total value of $4,014,450.00. Following the completion of the transaction, the director directly owned 97,351 shares of the company's stock, valued at $17,369,365.42. This represents a 18.77% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 1,649,489 shares of company stock worth $232,463,986. Insiders own 12.50% of the company's stock.

Astera Labs Trading Up 1.4%

ALAB stock traded up $2.37 during midday trading on Wednesday, hitting $176.61. The company had a trading volume of 3,126,453 shares, compared to its average volume of 5,376,900. Astera Labs, Inc. has a 52 week low of $36.85 and a 52 week high of $199.47. The stock's 50 day moving average price is $136.10 and its 200 day moving average price is $96.96. The stock has a market cap of $29.36 billion, a price-to-earnings ratio of 343.77, a PEG ratio of 4.62 and a beta of 1.48.

Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its earnings results on Tuesday, August 5th. The company reported $0.44 EPS for the quarter, beating analysts' consensus estimates of $0.33 by $0.11. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.The company had revenue of $191.93 million during the quarter, compared to the consensus estimate of $172.46 million. During the same quarter in the prior year, the company earned $0.13 earnings per share. The firm's revenue for the quarter was up 149.5% on a year-over-year basis. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. Analysts predict that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the company. Zacks Research raised Astera Labs to a "strong-buy" rating in a research note on Tuesday, August 12th. Stifel Nicolaus set a $145.00 target price on Astera Labs and gave the stock a "buy" rating in a research note on Monday, August 4th. Needham & Company LLC upped their target price on Astera Labs from $100.00 to $170.00 and gave the stock a "buy" rating in a research note on Wednesday, August 6th. Barclays reaffirmed an "overweight" rating and issued a $155.00 target price (up previously from $75.00) on shares of Astera Labs in a research note on Thursday, August 7th. Finally, Jefferies Financial Group upped their target price on Astera Labs from $95.00 to $130.00 and gave the stock a "buy" rating in a research note on Tuesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, Astera Labs currently has a consensus rating of "Moderate Buy" and an average price target of $142.00.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.